Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-01 4:49 pm Purchase |
2023-04-19 | 13G | 2seventy bio, Inc. TSVT |
Citadel Advisors LLC | 2,591,606 5.200% |
2,591,606 (New Position) |
Filing History |
| 2023-04-03 4:55 pm Purchase |
2023-03-23 | 13G | Design Therapeutics, Inc. DSGN |
Citadel Advisors LLC | 2,871,267 5.100% |
203,037 (+7.61%) |
Filing History |
| 2023-03-14 09:15 am Purchase |
2023-03-13 | 13G | Western Alliance Bancorporation WAL |
Citadel Advisors LLC | 5,935,538 5.400% |
5,935,538 (New Position) |
Filing History |
| 2023-03-06 4:11 pm Purchase |
2023-02-23 | 13G | Enliven Therapeutics, Inc. ELVN |
Citadel Advisors LLC | 2,298,756 5.600% |
2,298,756 (New Position) |
Filing History |
| 2023-02-27 4:02 pm Purchase |
2023-02-16 | 13G | Annexon, Inc. ANNX |
Citadel Advisors LLC | 2,500,307 5.200% |
1,018,285 (+68.71%) |
Filing History |
| 2023-02-14 09:52 am Sale |
2022-12-31 | 13G | StoneBridge Acquisition Corporation APAC |
Citadel Advisors LLC | 625,412 3.100% |
-1,054,173 (-62.76%) |
Filing History |
| 2023-02-14 08:26 am Sale |
2022-12-31 | 13G | Oklo Inc. OKLO |
Citadel Advisors LLC | 2,500,083 4.900% |
-624,762 (-19.99%) |
Filing History |
| 2023-02-14 08:26 am Sale |
2022-12-31 | 13G | Forum Merger IV Corporation FMIV |
Citadel Advisors LLC | 1,476,226 4.300% |
-312,588 (-17.47%) |
Filing History |
| 2023-02-14 08:26 am Sale |
2022-12-31 | 13G | Fusion Acquisition Corp. II FSNB |
Citadel Advisors LLC | 1,026,694 2.100% |
-2,273,876 (-68.89%) |
Filing History |
| 2023-02-14 08:26 am Sale |
2022-12-31 | 13G | Future Health ESG Corp. FHLT |
Citadel Advisors LLC | 109,397 1.700% |
-1,551,857 (-93.41%) |
Filing History |
| 2023-02-14 08:26 am Purchase |
2022-12-31 | 13G | Gores Holdings IX, Inc. GHIX |
Citadel Advisors LLC | 1,879,753 3.600% |
1,879,753 (New Position) |
Filing History |
| 2023-02-14 08:26 am Purchase |
2022-12-31 | 13G | Grove Collaborative Holdings, Inc. GROV |
Citadel Advisors LLC | 7,318 0.000% |
7,318 (New Position) |
Filing History |
| 2023-02-14 08:26 am Purchase |
2022-12-31 | 13G | Intuitive Machines, Inc. LUNR |
Citadel Advisors LLC | 2,212,089 6.700% |
61,841 (+2.88%) |
Filing History |
| 2023-02-14 08:26 am Sale |
2022-12-31 | 13G | Iris Acquisition Corp IRAA |
Citadel Advisors LLC | 1,504 0.100% |
-2,276,110 (-99.93%) |
Filing History |
| 2023-02-14 08:26 am Sale |
2022-12-31 | 13G | AN2 Therapeutics, Inc. ANTX |
Citadel Advisors LLC | 1,336,993 6.900% |
-24 (-0.00%) |
Filing History |
| 2023-02-14 08:26 am Sale |
2022-12-31 | 13G | JAWS Hurricane Acquisition Corporation HCNE |
Citadel Advisors LLC | 1,136,207 3.600% |
-679,793 (-37.43%) |
Filing History |
| 2023-02-14 08:26 am Purchase |
2022-12-31 | 13G | MoonLake Immunotherapeutics MLTX |
Citadel Advisors LLC | 2,886,092 7.400% |
2,886,092 (New Position) |
Filing History |
| 2023-02-14 08:26 am Purchase |
2022-12-31 | 13G | OmniAb, Inc. OABI |
Citadel Advisors LLC | 2,110,480 1.800% |
2,110,480 (New Position) |
Filing History |
| 2023-02-14 08:26 am Sale |
2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Citadel Advisors LLC | 1,384,499 3.000% |
-1,025,343 (-42.55%) |
Filing History |
| 2023-02-14 08:26 am Sale |
2022-12-31 | 13G | Pontem Corporation PNTM |
Citadel Advisors LLC | 503,550 0.700% |
-2,964,768 (-85.48%) |
Filing History |